free web stats

Risperdal and Invega


In a rush? You can use our Quick Contact Form to tell us the basic information about your case.


Off-Label Use By Children Can Result In Boys Developing Male Breasts (Gynecomastia)

Risperdal (risperidone) is a second-generation atypical antipsychotic that was given FDA approval for use in schizophrenic adults in the early 1990’s. Janssen Pharmaceuticals, the manufacturer of Risperdal, attempted to obtain FDA approval for a child and adolescent indication in the late 1990’s through 2006 and was turned down on multiple occassions. Nonetheless, Janssen aggressively marketed Risperdal off label to children.

The issue is Risperdal causes rapid increases in prolactin levels (hormone responsible for breast formation and lactation) that in turn causes gynecomastia (breast formation) in adolescent males.

This same male breasts drug side effect is associated with Invega (paliperidone), another atypical antipsychotic agent from Janssen Pharmaceuticals.  Invega was approved by the FDA in 2006 for the treatment of schizophrenia in adults and adolescents (ages 12 – 17).

While the Risperdal Package Insert, or drug label, stated there was less than a 1/1000 chance of developing gynecomastia, Janssen was sitting on multiple studies showing 78 percent of boys ingesting Risperdal suffered from hyperprolactinemia with 5-8 percent going on to suffer gynecomastia – far more than the .01% risk set forth in their label.

If you think that a boy might have developed breasts due to his use of Risperdal or Invega, the first thing to do is to have him see a medical doctor for gynecomastia tests and diagnosis.

In turn, if gynecomastia is diagnosed, there may be a possible legal claim seeking compensation that can be brought against the drug company, Janssen Pharmaceuticals, on behalf of the boy who has developed breasts from using Risperdal or Invega. For that you should consult an experienced drug injury lawyer.

Risperdal Drug Injury Case Evaluation >>


Earlier articles by attorney Tom Lamb on the Side Effects Blog:


All content by attorney Tom Lamb

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, NC 28403
(800) 426-9535
Disclaimer and Copyright